Percorrendo por Autor SOARES, ANDREY
Mostrando regs. 1 a 8 de 8
Data de publicação | Título | Autor(es) |
2021 | A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415) | MALUF, FERNANDO C.; SCHUTZ, FABIO A.; CRONEMBERGER, EDUARDO H., et al |
2022 | A Systematic Review and Meta-Analysis of the Role of Immune Checkpoint Inhibitors (ICI) as Adjuvant Treatment for Localized High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC) | MONTEIRO, FERNANDO SABINO M.; SOARES, ANDREY; SOUZA, VINICIUS CARRERA, et al |
2020 | First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis | MONTEIRO, FERNANDO SABINO M.; SOARES, ANDREY; DEBIASI, MÁRCIO, et al |
2022 | Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515) | BASTOS, DIOGO A.; GONGORA, ALINE BOBATO LARA; DZIK, CARLOS, et al |
2022 | -Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil- | JARDIM, DENIS L.; GONÇALVES E SILVA, ADRIANO; POMPEO, ALEXANDRE SAAD FERE LIMA, et al |
2019 | Renal cell cancer treatment: an expert panel recommendation from the Latin American cooperative group-genitourinary and the Latin American renal cancer group: focus on surgery | DE CÁSSIO ZEQUI, STÊNIO; DA COSTA, WALTER HENRIQUES; KORKES, FERNANDO, et al |
2022 | Survival analysis of the randomized phase II trial to investigate androgen signaling inhibitors with or without androgen deprivation therapy (ADT) for castration-sensitive prostate cancer: LACOG 0415 | MALUF, FERNANDO C.; SOARES, ANDREY; BASTOS, DIOGO ASSED, et al |
2019 | Tratamento do câncer avançado de próstata: Onde estamos em 2019? | MONTEIRO, FERNANDO SABINO MARQUES; SOARES, ANDREY; OLIVEIRA, FERNANDO NUNES GALVÃO DE, et al |